MPPP Task Forces
From time to time, a Partnership’s Board or Steering Committee may appoint working groups of persons possessing special knowledge or expertise for the development of programs, tasks, and activities, or to perform other actions which promote the objectives of the Partnership.
For their duration, each of the task forces (or action item committees) will have a leader(s), a defined work scope, a list of deliverable items, and an expected completion date.
Note: Task Force deliverable products (when available) are posted on this Pavement website at Technical / Task Force Products.
| Task Force | “Webinar / Roundtable” as of October 22, 2026 |
| Leader(s) | Rob Green (Michigan DOT) Co-Chair, Andre Dupuis (Manitoba DOT) |
| Work Scope |
|
| Deliverable Products / Expected Completion |
|
| Task Force | “Data Group” as of October 22, 2026 |
| Leader(s) | Nicole Andre (Saskatchewan Highways) |
| Work Scope |
|
| Deliverable Products / Expected Completion |
|
| Subs Tasks | ||||
| Priority | Activity | Sub-Tasks | Projected Completion | Responsible Party |
| #1. State Treatment and Specifications Database | Maintain Website with Agency Treatment Data | 1A-1 Review and Update Treatment List Annually
The treatment toolbox varies from one state to another. The list of treatments will be regularly reviewed to add to the list or update definitions. 1A-2 Provide Estimated Treatment Life State DOTs and local agencies have different experiences with the longevity of their treatments. This sub-task will provide the estimated treatment life for those treatments used by the agency and be updated as experience is gained. 1A-3 Furnish Treatment Estimated Life Extensions Forecasting the pavement life extending value is an important aspect of using a pavement preservation treatment. The task force will collect estimated life extension for the treatments used by the agency. 1A-4 Add Treatment Average Cost Data Treatment costs vary with the size and project location. The average cost and other project data for each treatment will be collected to help agencies prepare estimates when trying a new treatment. 1B-1 Compile Treatment Specifications and Special Provisions State DOTs and local agencies have written specifications for the treatments they use. Agencies writing a treatment specification for the first time, or improving an existing specification, can be assisted with examples of other specifications used in the region. The goal is to collect current specifications and display them on the partnership website 1B-2 Maturity of Specification Use It is important that agencies reviewing the specification database know the number of years that a specification has been in use. The date of specification development will be indicated and amount of use (Rarely, Occasional, Often). 1B-3 Attain the Degree of Success Using the Specification Specifications have varying levels of success. Knowing the historical success of a treatment specification is an important aspect of an agency’s review process. Specifications collected will be marked as: Consistently Proven, Proven, or Incomplete. |
Treatment Quantity & Cost Database Housed on website.
Ongoing annual call for data. Survey Completed June 2025 Ongoing development |
Data Collection Task Force |
| Task Force | “Proposed Research” |
| Leader(s) | Ashley Buss (Iowa DOT) |
| Work Scope |
|
| Deliverable Products / Expected Completion |
|
